LONCASTUXIMABUM TESIRINUM – vedlejsiucinky.cz
(INNF)
LONCASTUXIMAB TESIRINA(INNS)
LONCASTUXIMAB TESIRIN(INND)
LONKASTUXIMAB TESIRIN(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS CD19 (B LYMPHOCYTE SURFACE ANTIGEN B4, LEU-12)], CHIMERIC MONOCLONAL ANTIBODY CONJUGATED TO THE PYRROLOBENZODIAZEPINE (PBD) DIMER SCX; GAMMA1 HEAVY CHAIN (1-449) [MUS MUSCULUS VH (IGHV1-69*02 (85.70%) -(IGHD) -IGHJ4*01) [8.8.13] (1-120) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 (CH1 R120>K (217) (121-218), HINGE (219-233), CH2 (234-343), CH3 E12 (359), M14 (361) (344-448), CHS K2>DEL (449)) (121-449)], (223-211')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-211') [MUS MUSCULUS V-KAPPA (IGKV4-70*01 (91.40%) - IGKJ1*01) [5.3.7] (1'-104') -HOMO SAPIENS IGKC*01, KM3 A45.1 (150), V101 (188) (105'-211')]; DIMER (229-229'':232-232'')-BISDISULFIDE; CONJUGATED, ON AN AVERAGE OF 2 TO 3 CYSTEINES, TO THE PYRROLOBENZODIAZEPINE (PBD) DIMER SCX, VIA A CLEAVABLE (VALINE-ALANINE DIPEPTIDE AS CATHEPSINE B CLEAVAGE SITE) MALEIMIDE TYPE LINKER CONTAINING A SPACER PEG (N=8) CORRECTED RECOMMENDED INN: LIST 90(WHO)
LONCASTUXIMABUM TESIRINUM(INN)